The semicolon sign: Dopamine transporter imaging artifact from head tilt

Journal of Nuclear Medicine Technology

Volumn 41, Issue 2, 2013, Pages 105-107

  Covington, Matthew F ^a   McMillan, Natalie A ^a   Avery, Ryan J ^a   Kuo, Phillip H ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Basal ganglia; Dopamine transporter (DAT) imaging; Imaging artifact; Parkinson disease

Indexed keywords

DOPAMINE TRANSPORTER;

ARTICLE; ARTIFACT; BASAL GANGLION; CAUDATE NUCLEUS; DOPAMINE TRANSPORTER IMAGING; HEAD HOLDER; HEAD MOVEMENT; HEAD TILTING; IMAGING; NUCLEAR MEDICINE; PARKINSON DISEASE; PARKINSONISM; PUTAMEN; QUALITY CONTROL;

BASAL GANGLIA; DOPAMINE TRANSPORTER (DAT) IMAGING; IMAGING ARTIFACT; PARKINSON DISEASE;

ARTIFACTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HEAD; HUMANS; MOLECULAR IMAGING; MOVEMENT; PATIENT POSITIONING;

EID: 84878823398     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.112.117184     Document Type: Article

References (6)

1. Ravina B, Marek K, Eberly S, et al. Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Mov Disord. 2012;27: 1392-1397.
2. Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP. [123I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord. 2001;16: 1023-1032.
3. Gunning-Dixon FM, Head D, McQuain J, Acker JD, Raz N. Differential aging of the human striatum: a prospective MR imaging study. AJNR. 1998;19:1501-1507.
4. Djang DSW, Janssen MJR, Bohnen N, et al. SNM practice guideline for dopamine transporter imaging with 123 I-ioflupane SPECT 1.0. J Nucl Med. 2012;53:154-163.
5. Tatsch K, Poepperl G. Quantitative approaches to dopaminergic brain imaging. Q J Nucl Med Mol Imaging. 2012;56:27-38.
6. Zubal IG, Early M, Yuan O, et al.Optimized, automated striatal uptake analysis applied to SPECT brain scans of Parkinson's disease patients. J Nucl Med. 2007;48:857-864.